🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Valid Gahramanov

Tel Aviv University

ORCID: 0000-0002-7504-5583

Also affiliated with Ariel University

Biochemistry, Genetics and Molecular BiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: Evolution of resistance to Irinotecan in cancer cells involves generation of topoisomerase-guided mutations in non-coding genome that reduce the chances of DNA breaks.

0 citations

Valid Gahramanov, Shivani Patel, Julia A. Yaglom, Lukasz Kaczmarczyk, Ivan A. Alexandrov +4 more

12 citations

Valid Gahramanov, Shivani Patel, Julia A. Yaglom, Lukasz Kaczmarczyk, Ivan A. Alexandrov +4 more

2 citations

Corinne Dilsavor, Valid Gahramanov, Erin Floyd, Jane Ding, John Glynn +5 more

0 citations

Assaf Grunwald, Valid Gahramanov, Michal Hameiri-Grossman, Elena Shinderman-Maman, Dafna Gaas +10 more